Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.

Oh JJ, Byun SS, Lee SE, Hong SK, Jeong CW, Kim D, Kim HJ, Myung SC.

Gene. 2014 Jan 1;533(1):86-93. doi: 10.1016/j.gene.2013.09.119. Epub 2013 Oct 9.

PMID:
24120391
2.

Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.

Oh JJ, Byun SS, Lee SE, Hong SK, Jeong CW, Choi WS, Kim D, Kim HJ, Myung SC.

Prostate Cancer Prostatic Dis. 2014 Jun;17(2):149-56. doi: 10.1038/pcan.2014.1. Epub 2014 Feb 4.

PMID:
24492489
3.

Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.

Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T.

Cancer Res. 2000 Jan 15;60(2):305-8.

4.

Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population.

Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Koike H, Nakazato H, Okugi H, Hasumi M, Fukabori Y, Kurokawa K, Yamanaka H.

Int J Urol. 2003 May;10(5):261-6.

5.

Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.

Onen IH, Ekmekci A, Eroglu M, Konac E, Yesil S, Biri H.

Exp Biol Med (Maywood). 2008 Dec;233(12):1608-14. doi: 10.3181/0803-RM-110. Epub 2008 Oct 10.

PMID:
18849534
6.

Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China.

Bai Y, Yu Y, Yu B, Ge J, Ji J, Lu H, Wei J, Weng Z, Tao Z, Lu J.

BMC Med Genet. 2009 Dec 4;10:125. doi: 10.1186/1471-2350-10-125.

7.
8.

Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.

Zhang Q, Shan Y.

J BUON. 2013 Oct-Dec;18(4):961-9. Review.

PMID:
24344024
9.

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA.

J Natl Cancer Inst. 1997 Jan 15;89(2):166-70.

PMID:
8998186
10.

Variants in the HEPSIN gene are associated with susceptibility to prostate cancer.

Kim HJ, Han JH, Chang IH, Kim W, Myung SC.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):353-8. doi: 10.1038/pcan.2012.17. Epub 2012 Jun 5.

PMID:
22665141
11.

Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S.

Cancer Detect Prev. 2009;32(5-6):386-94.

PMID:
19588543
12.

Vitamin D receptor polymorphisms and prostate cancer risk in Brazilian men.

Maistro S, Snitcovsky I, Sarkis AS, da Silva IA, Brentani MM.

Int J Biol Markers. 2004 Jul-Sep;19(3):245-9.

PMID:
15503828
13.
14.

Vitamin D receptor gene polymorphism and prostate cancer risk.

Gsur A, Madersbacher S, Haidinger G, Schatzl G, Marberger M, Vutuc C, Micksche M.

Prostate. 2002 Apr 1;51(1):30-4.

PMID:
11920955
15.

HNF1B polymorphism associated with development of prostate cancer in Korean patients.

Kim HJ, Bae JS, Lee J, Chang IH, Kim KD, Shin HD, Han JH, Lee SY, Kim W, Myung SC.

Urology. 2011 Oct;78(4):969.e1-6. doi: 10.1016/j.urology.2011.06.045.

PMID:
21982019
16.

Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.

Kim HJ, Bae JS, Chang IH, Kim KD, Lee J, Shin HD, Lee JY, Kim WJ, Kim W, Myung SC.

World J Urol. 2012 Apr;30(2):225-32. doi: 10.1007/s00345-011-0690-3. Epub 2011 May 7.

PMID:
21553150
17.

Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.

Kim MS, Lee HN, Kim HJ, Myung SC.

Int Braz J Urol. 2015 Sep-Oct;41(5):869-97. doi: 10.1590/S1677-5538.IBJU.2014.0041.

18.

Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.

Patiño-García B, Arroyo C, Rangel-Villalobos H, Soto-Vega E, Velarde-Félix JS, Gabilondo F, Sandoval-Ramirez L, Figuera LE.

Rev Invest Clin. 2007 Jan-Feb;59(1):25-31.

PMID:
17569297
19.

Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.

Jingwi EY, Abbas M, Ricks-Santi L, Winchester D, Beyene D, Day A, Naab TJ, Kassim OO, Dunston GM, Copeland RL Jr, Kanaan YM.

Anticancer Res. 2015 Mar;35(3):1549-58.

20.

The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.

Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C.

J Hum Genet. 2002;47(8):413-8.

PMID:
12181642

Supplemental Content

Support Center